Article and Video CATEGORIES
Dr. Duma is an Assistant Professor and Thoracic Oncologist at @UWcarbone and Former Chief Fellow @MayoClinic in Rochester, Minnesota. In addition to her dedication to her patients as a provider, Dr. Duma is committed to her research and advocacy in diversity and inclusion. She was recognized as the 2018 resident of the year by the National Hispanic Medical Association.
Narjust Duma, MD, Assistant Professor and Thoracic Oncologist at the University of Wisconsin Carbone Cancer Center discusses COVID 19 and how it affects the community.
This 2 part series, presented in Spanish for the Latino community, covers information relating to the following topics. Please scroll down for part 2 of this important series.
What is coronavirus?
¿Qué es el COVID-19?
What are the common symptoms?
¿Cuales son los síntomas mas comunes de la infección COVID-19?
How is it contracted, and how can it be prevented?
¿Qué puedo hacer para evitar contraer COVID-19?
Who is at risk, and are people with cancer at higher risk?
¿Las personas con cáncer deberían tomar precauciones especiales?
Does the risk of exposure change my treatment for cancer?
¿Puede el riesgo de exposición al virus cambiar mi tratamiento para el cáncer? ¿Como va a cambiar mi interacción con mi doctor del cáncer?
What happens if I get coronavirus and have cancer?
¿Que pasa si me contraigo el coronavirus?
¿Puedo seguir con mi tratamiento para el cáncer?
I hear about treatments: are these now established as effective?
¿Hay tratamientos para COVID-19?
¿Puede la inmunoterapia protegerme en contra del COVID-19?
For more, please visit http://cancerGRACE.org/. To join the conversation, visit https://cancergrace.org/forum.
Please feel free to offer comments and raise questions in our
discussion forums.
Related Content
Forum Discussions
Hi amitchouhan,
Welcome to Grace. At this time, there aren't any targeted therapies to treat SCLC, but there are new treatments. Check out our latest OncTalk webinar from December. The last...
I was searching for this, Thank you so much for the info.